Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.

Clinical trial NCT06754540 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06754540
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Relapse

Start date: 2025-01-16
Primary completion: 2027-01-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.